Gene therapy for neurometabolic disorders

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 48/00 (2006.01) C12N 15/63 (2006.01) C12N 15/74 (2006.01) C12N 15/86 (2006.01)

Patent

CA 2607173

The disclosure pertains to methods and compositions for treating disorders affecting the central nervous system (CNS). These disorders include neurometabolic disorders such as lysosomal storage diseases that affect the central nervous system, e.g., Niemann-Pick A disease. They also include disorders such as Alzheimer's disease. The disclosed methods involve contacting an axonal ending of a neuron with a composition containing high titer AAV carrying a therapeutic transgene so that the AAV vector is axonally transported in a retrograde fashion and transgene product is expressed distally to the administration site.

L'invention porte sur des procédés et des compositions de traitement de troubles affectant le système nerveux central (CNS). Parmi ces troubles figurent des troubles neurométaboliques tels que les maladies lysosomales qui affectent le système nerveux central, par exemple la maladie de Niemann-Pick, ainsi que des troubles tels que la maladie d'Alzheimer. Les procédés de l'invention consistent à mettre en contact une terminaison axonale d'une neurone avec une composition contenant un virus associé aux adénovirus (AAV) transportant un transgène thérapeutique si bien que le vecteur AAV soit axonalement transporté de manière rétrograde et que le produit transgénique soit exprimé de manière distale au site d'administration.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Gene therapy for neurometabolic disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Gene therapy for neurometabolic disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gene therapy for neurometabolic disorders will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1446926

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.